Journal of Health and Productivity (JHP)

Journal of Health and Productivity (JHP) Journal of Health and Productivity | ISSN 2164-4373 JHP also is distributed to payers, insurers, providers, consultants and policymakers.
(2)

The Journal of Health & Productivity (JHP) is an international comprehensive peer-reviewed journal published by the Institute of Health and Productivity (IHPM) that publishes original research, editorial comments, review articles and news on the relationship between employee health and work-related productivity. The journal helps inform decision makers in both the private and public sectors on iss

ues related to the health and productivity cost, burden of health risk factors and common disease conditions, and the impact that innovative health and productivity management programs have on medical and productivity-related outcomes. The journal is published for medical directors, health and wellness managers, directors of human resources, and senior executive management of large companies. Editor in Chief
William B. Bunn, III, MD, JD, MPH
VP, Health, Safety, Security & Productivity, Navistar International
Professor, Northwestern University School of Medicine

Listen to the latest episodes of The Onco'Zine Brief
03/20/2024

Listen to the latest episodes of The Onco'Zine Brief

The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcar...

12/12/2023

The The Onco'Zine Brief with Peter Hofland on UK Health Radio - Peter talks with Steven Spellman, Vice President and Senior Scientific Director at Center for International Blood & Marrow Transplant Research (CIBMTR). They discuss the cryopreservation of hematopoietic cell grafts on overall survival (OS) and other outcomes within 1 year after hematopoietic cell transplantation.

👉🏼 🎧 https://bit.ly/47QNWIi

10/06/2023

In a new episode of The Onco'Zine Brief, Peter Hofland talks with Dr Eli Benaim, the Chief Medical Officer and Executive Vice President Development at SonALAsense and Dr Mark De Souza, President and Chief Executive Officer of SonALAsense. SonALAsense was founded to create hope in the face of despair...

https://doi.org/10.14229/onco.2023.10.02.001
10/03/2023

https://doi.org/10.14229/onco.2023.10.02.001

Loneliness and depression significantly impact the psychological and physical well-being of older individuals diagnosed with cancer or hematological diseases. This paper reviews the intricate relationship between loneliness, depression, and their effects on older adults’ health outcomes. Through a...

09/19/2023

Gene therapy is emerging as a potential cure for those battling sickle cell disease, offering optimism for those affected by this debilitating condition. For this promise to be realized, however, significant barriers to access must be mitigated. In this article, we delve into challenges faced by vul...

09/18/2023

Intensity-modulated radiation therapy, also known as IMRT, should be utilized for treatment of locally advanced Non-Small Cell Lung Cancer (NSCLC) to reduce the risk of severe pulmonary toxicity and radiation exposure to the heart.

Find ADC related news in the ADC Directory at www.adcdirectory.com - The ADC Directory is a membership driven companion ...
09/11/2023

Find ADC related news in the ADC Directory at www.adcdirectory.com - The ADC Directory is a membership driven companion to ADC Review / Journal of Antibody-drug Conjugates. Click on the link below to sign up an join the community!

The ADC Directory provides a seamless exchange of information between businesses and professionals focused on the research, development and manufacture of antibody-drug conjugates. Members have the opportunity to share reviews, articles, videos, events, products, career opportunities and more.

While pricing controls imposed by the Inflation Reduction Act of 2022 (IRS) may appear positive for patients in the shor...
08/17/2023

While pricing controls imposed by the Inflation Reduction Act of 2022 (IRS) may appear positive for patients in the short term, and is considered a step forward in improving affordability of, and access to, innovative medical treatments, these controls may have unintended consequences on biopharmaceutical drug development programs and investments in the long term unless this pressure is offset by the opportunity to modernize the way clinical trials are conducted.

The Inflation Reduction Act of 2022 (IRA) covers new and reinstated tax laws that will affect individuals and businesses. Through IRA, President Biden delivered on his promise to lower prescription drug costs by allowing, for the first time, the U.S. Centers for Medicare & Medicaid Services (CMS) to...

Help The Onco'Zine Brief -- a radio show/podcast about    ,   development, and much more -- reach a wider audience.
04/06/2023

Help The Onco'Zine Brief -- a radio show/podcast about , development, and much more -- reach a wider audience.

Nationally Syndicated Radio: Building audience trust for more than 5 years. | Check out 'The Onco’Zine Brief with Peter Hofland' on Indiegogo.

https://conta.cc/3XcAZlYWith a growing number of in clinical trials, a plethora of positive clinical results, and an exp...
02/08/2023

https://conta.cc/3XcAZlY
With a growing number of in clinical trials, a plethora of positive clinical results, and an expansion of ADCs to novel indications, there has been no more important time to invest in progressing your ADCs and unite the community.

Sign up to Stay in Touch!Signing up for the Onco'Zine eNewsletter is quick, easy … and FREE! Sign up to receive our eNew...
02/07/2023

Sign up to Stay in Touch!

Signing up for the Onco'Zine eNewsletter is quick, easy … and FREE! Sign up to receive our eNewsletter with links to our featured podcast, online articles, the latest health news, physician and industry expert interviews, society and industry conference updates, and much more.

https://bit.ly/OncoZine_Newsletter

https://exchange.prx.org/p/458032 or https://bit.ly/TOB-Jan_16_2023In the 100th episode of the Onco'Zine Brief, Peter Ho...
01/20/2023

https://exchange.prx.org/p/458032 or https://bit.ly/TOB-Jan_16_2023

In the 100th episode of the Onco'Zine Brief, Peter Hofland, Ph.D. talks with Stephen Spellman, Vice President of Research and Senior Scientific Director of the Center for International Blood and Marrow Transplant Research at the National Marrow Donor Program/Be the Match.

In the program today Hofland and Spellman talk about bone-marrow transplants.

The likelihood of finding a fully matched unrelated donor for a patient who needs a bone marrow transplant varies greatly depending on a patient's ethnic background, and that ethnically diverse patients have – historically – been at a disadvantage. However, new research shows that when donor registry models are expanded to include mismatched unrelated donors, finding access for patients may greatly improve.[1]

Based on this understanding, Spellman believes that mismatched unrelated donors hold the key to erasing the gap in donor availability and deliver allogeneic hematopoietic cell transplantation (HCT) to all patient populations.

About The Onco'Zine Brief
The Onco'Zine Brief is distributed in the United States via PRX (Public Radio Exchange). In the United Kingdom and Europe, the program is distributed via UK Health Radio (UKHR). And the program can be downloaded via most podcasts and streaming media services, including iTunes, Spotify, TuneIn, and iHeart Radio.

For more information about The Onco'Zine Brief or how to sponsor or support this public radio broadcast and podcast, download our Media Kit https://lp.constantcontactpages.com/su/jj9JqsS/MediaKit202122/ , visit Patreon at https://www.patreon.com/theoncozinebrief or contact the sales team at https://www.oncozine.com/advertisement-sponsorship-options/

For more information about cancer and cancer treatments, visit our online journal Onco'Zine at www.oncozine.com

To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.

The Onco’Zine Brief is made possible, in part, by Java Original Coffee – the home of artisan roasted coffee. Order no at www.javaoriginalcoffee.com

Reference
[1] Spellman S. Is finding a Donor for All in Need of Allogeneic HCT Possible? New Modeling Says Yes - Onco'Zine on September 5, 2022.

https://exchange.prx.org/p/458032 or https://bit.ly/TOB-Jan_16_2023

Click on the link to read the Onco'Zine and ADC Review newsletter with updates from the San Antonio Breast Cancer Sympos...
12/30/2022

Click on the link to read the Onco'Zine and ADC Review newsletter with updates from the San Antonio Breast Cancer Symposium (SABCS): https://conta.cc/3hj7b8p

Address

Phoenix, AZ
85004

Alerts

Be the first to know and let us send you an email when Journal of Health and Productivity (JHP) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Journal of Health and Productivity (JHP):

Share

Nearby media companies